Dry Eye Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL)), By End Use (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2019-2029F

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Dry Eye Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Broadband Light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL)), By End Use (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2019-2029F

Forecast Period2025-2029
Market Size (2023)USD 282.14 Million
CAGR (2024-2029)8.25%
Fastest Growing SegmentMeibomian Gland Expression (MGX)
Largest MarketNorth America
Market Size (2029)USD 441.99 Million

MIR Medical Devices

Market Overview

Global Dry Eye Treatment Devices Market w

New and innovative technologies are providing more effective and precise solutions for patients suffering from dry eye.

Key Market Drivers

Rising Aging Population

The global healthcare landscape is witnessing a profound shift as the world's population ages. The aging demographic is giving rise to various health challenges, one of which is the increasing prevalence of dry eye syndrome. Dry eye syndrome is a common condition characterized by a lack of sufficient moisture and lubrication on the surface of the eye, leading to discomfort and visual disturbances. As the elderly population grows, the demand for dry eye treatment devices is on the rise.

Increased Screen Time

In today's digital age, our lives are becoming increasingly intertwined with screens, whether for work, entertainment, or communication. While the convenience of digital devices has revolutionized the way we live and work, it has also given rise to a concerning issue – increased screen time and its adverse effects on eye health. One such consequence is the growing prevalence of dry eye syndrome, which has led to the expansion of the global dry eye treatment devices market

Growing awareness about dry eye syndrome and its debilitating effects has led to an increase in patient visits to eye care professionals. Early diagnosis and treatment have become essential, contributing to the demand for dry eye treatment devices. The dry eye treatment devices market has benefited from continuous technological advancements, such as the development of cutting-edge devices that provide more effective and comfortable treatments. These include innovative methods for tear production stimulation, ocular surface hydration, and inflammation reduction.


MIR Segment1

Key Market Challenges

Complex Nature of Dry Eye Syndrome and

Dry eye syndrome is not a one-size-fits-all condition. It can result from various factors, such as age, hormonal changes, environmental conditions, and underlying health issues. Treating dry eye effectively requires a personalized approach, which poses a challenge for device manufacturers. Developing devices that cater to the diverse needs of dry eye patients is a complex task, as what works for one individual may not work for another.

Key Market Trends

Technological Advancements

Innovations

IPL devices use controlled flashes of light to open and clear the meibomian glands, which are responsible for producing the oily layer of the tear film. This technology has shown promising results in alleviating dry eye symptoms.


MIR Regional

Segmental Insights

Technology Insights

Based

End Use Insights

Based on End Use, Hospitals & Clinics have emerged as the fastest growing segment in the

Regional Insights

Based on Region, North America have emerged as the dominant region in the Global Dry Eye Treatment Devices Market in 2023, holding the largest market share in terms of value. North America, particularly the United States, is home to a thriving medical technology industry. The continuous research and development efforts in the region have led to the creation of cutting-edge dry eye treatment devices. This technological edge has made North America a global leader in the market.

Recent Developments

  • In December 2023, AMETEK, Inc., a global leader in the design, engineering, and manufacturing of diagnostic devices for eye care, announced an exclusive partnership with SBM Sistemi of Italy to distribute SBM’s imaging and dry eye assessment and treatment devices in the United States. This comprehensive range of devices offers flexibility and represents the most extensive family of ocular surface assessment technologies available. Among these devices, the Reichert-SBM IDRA stands out as the world’s most comprehensive system for supporting dry eye diagnosis. The IDRA evaluates all tear film layers (Lipid, Aqueous, and Mucin) and the Meibomian Glands to identify specific types of DED and provide personalized treatment recommendations based on the patient’s needs. Both the IDRA and OS1000 ocular surface evaluation devices were specifically designed for quick, painless, and non-invasive assessment of DED, delivering accurate, reproducible, and objective results. The Reichert-SBM OS1000 is an integrated diagnostic platform that combines a corneal topographer with DED assessment, enabling eye care professionals to conduct various DED and topography tests with a single device, thereby enhancing operational efficiency and minimizing capital expense for practices. Lastly, the Reichert-SBM DEM100-DSLC200 is an anterior imaging camera system compatible with a wide range of slit lamps, offering comprehensive DED assessment capabilities.

Key Market Players

  • MiBo Medical Group
  • Sight Sciences, Inc. 
  • Lumenis Be Ltd.
  • ESW Vision SAS
  • Johnson &Johnson Vision Care, Inc. 
  • Alcon, Inc. 

By Technology

By End Use

By Region

  • Broadband Light (BBL)
  • Intense Pulsed Light (IPL)
  • Meibomian Gland Expression (MGX)
  • Combination (MGX+IPL)
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.